{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:23:58Z","timestamp":1787664238543,"version":"build-2736575974"},"reference-count":36,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Acute rhinosinusitis is associated with a substantial deterioration in quality of life, including symptoms such as nasal obstruction, facial pressure, cough, and sleep disruption. Growing interest in non-pharmacological management strategies has been observed, particularly among populations in whom systemic treatments may be limited, such as pediatric patients and pregnant individuals. NESOSPRAY HE-G is a nasal device containing a filmogenic glycerol formulation designed to create a protective barrier and induce an osmotic effect, thereby promoting nasal decongestion and mucosal protection. Materials and Methods: A randomized, double-blind, placebo-controlled study was conducted to assess the performance and safety of NESOSPRAY HE-G (n = 20) compared with a saline comparator (n = 20) in patients aged 3 years and older presenting with acute rhinosinusitis and a baseline Rhino-Sinusitis Severity Score (RSSS) of at least 25\/50. The investigational product was administered as three sprays per nostril, four times daily, over a maximum period of 15 days or until symptom resolution. Efficacy was primarily evaluated through changes in the total RSSS and in key symptoms, including nasal congestion, facial pain, cough, sleep disturbance, and fever. Safety assessments included monitoring adverse events (AE) and evaluating local tolerability. Results: Baseline characteristics were comparable between groups. Treatment with NESOSPRAY HE-G resulted in a statistically significant reduction in total RSSS from Day 2 onwards, with sustained effects throughout the study period. Improvements were also observed across individual symptoms, including early relief of nasal congestion and reductions in cough and facial pain, with faster onset compared to the comparator. Sleep quality showed progressive improvement. Resolution of fever occurred in both groups, with an earlier effect observed in the NESOSPRAY HE-G arm. No serious adverse events (SAE) or hypersensitivity reactions were reported. The product demonstrated good tolerability. Conclusions: NESOSPRAY HE-G provides rapid and sustained alleviation of symptoms associated with acute rhinosinusitis. Its topical mode of action, based on osmotic activity and barrier formation, represents a suitable non-pharmacological option, particularly for patients seeking alternatives to systemic therapies or presenting contraindications to such treatments.<\/jats:p>","DOI":"10.3390\/medicina62091631","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:57:17Z","timestamp":1787662637000},"page":"1631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Efficacy and Safety of a Nasal Medical Device (NESOSPRAY HE-G) in Acute Rhinosinusitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9577-9107","authenticated-orcid":false,"given":"Marine","family":"Delmas","sequence":"first","affiliation":[{"name":"Vitrobio, ZAC de Lavaur, 63500 Issoire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"D\u2019Almeida","sequence":"additional","affiliation":[{"name":"Vitrobio, ZAC de Lavaur, 63500 Issoire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Dameron-Puech","sequence":"additional","affiliation":[{"name":"Vitrobio, ZAC de Lavaur, 63500 Issoire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Shrivastava","sequence":"additional","affiliation":[{"name":"Vitrobio, ZAC de Lavaur, 63500 Issoire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11882-014-0443-7","article-title":"Acute Rhinosinusitis in Children","volume":"14","author":"Nocon","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_2","first-page":"1057","article-title":"Acute Rhinosinusitis in Adults","volume":"83","author":"Aring","year":"2011","journal-title":"Am. Fam. Physician"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1399-3038.2012.01321.x","article-title":"Management of Acute Rhinosinusitis","volume":"23","author":"Mori","year":"2012","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11882-020-00917-5","article-title":"Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020","volume":"20","author":"Jaume","year":"2020","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11882-018-0761-2","article-title":"Inflammatory Biomarkers During Bacterial Acute Rhinosinusitis","volume":"18","author":"Autio","year":"2018","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic Rhinosinusitis in Europe\u2014An Underestimated Disease. A GA2LEN Study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaip.2022.01.016","article-title":"Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors","volume":"10","author":"Sedaghat","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11882-015-0583-4","article-title":"Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis","volume":"16","author":"Scheckenbach","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2165\/00019053-200422130-00002","article-title":"Acute Rhinosinusitis: A Pharmacoeconomic Review of Antibacterial Use","volume":"22","author":"Wasserfallen","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/00016480500416835","article-title":"Prevalence of Upper and Lower Airway Symptoms: The Sk\u00f6vde Population-Based Study","volume":"126","author":"Akerlund","year":"2006","journal-title":"Acta Otolaryngol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.anorl.2012.09.005","article-title":"Rebound Congestion and Rhinitis Medicamentosa: Nasal Decongestants in Clinical Practice. Critical Review of the Literature by a Medical Panel","volume":"130","author":"Mortuaire","year":"2013","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-3038.2012.01319.x","article-title":"Diagnosis of Acute Rhinosinusitis","volume":"23","author":"Esposito","year":"2012","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0054.7506","article-title":"Rational Treatment of Acute Rhinosinusitis in the Context of Increasing Antibiotic Resistance","volume":"78","author":"Arcimowicz","year":"2024","journal-title":"Pol. J. Otolaryngol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Barche, F.-Z.E., D\u2019almeida, M., Dameron, S., and Shrivastava, R. (2025). Clinical Evaluation of NESOSPRAY HE-C, a Nasal Spray, for Rhinopharyngitis and Rhinosinusitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Medicina, 61.","DOI":"10.3390\/medicina61061071"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jaip.2020.01.064","article-title":"Sinonasal Disease: An Underappreciated Entity","volume":"8","author":"Naclerio","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_17","first-page":"1","article-title":"The Impact of Pregnancy Associated Hormonal Changes on Sinusitis and Rhinitis: A Narrative Review","volume":"10","author":"Yaghoubi","year":"2024","journal-title":"J. Otorhinolaryngol. Facial Plast. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Grajczyk, A., Sobczyk, K., Zarzecka, J., Barcz, E., and D\u017caman, K. (2024). Objective Measurements of Nasal Obstruction and Eustachian Tube Function in Pregnant Women. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092671"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dumitru, C.S., Zara, F., Novacescu, D., Szekely, D., Iovanescu, D., Iovanescu, G., Patrascu, R., and Dumitru, C. (2025). Pregnancy Rhinitis: Pathophysiological Mechanisms, Diagnostic Challenges, and Management Strategies-A Narrative Review. Life, 15.","DOI":"10.3390\/life15081166"},{"key":"ref_20","first-page":"e55544","article-title":"Physiological Changes in Pregnant Women Due to Hormonal Changes","volume":"16","author":"Jee","year":"2024","journal-title":"Cureus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4193\/Rhino15.228","article-title":"Management of Rhinosinusitis during Pregnancy: Systematic Review and Expert Panel Recommendations","volume":"54","author":"Lal","year":"2016","journal-title":"Rhinology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pietra\u015b, A., and Mielnik-Niedzielska, G. (2022). Acute Rhinosinusitis in Children with Inhalant Allergies. Children, 9.","DOI":"10.3390\/children9060836"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.otc.2014.06.003","article-title":"Pediatric Rhinosinusitis","volume":"47","author":"Magit","year":"2014","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"ref_24","first-page":"3","article-title":"Management of Acute Rhinosinusitis in Children","volume":"56","author":"Wannasuphoprasit","year":"2025","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_25","first-page":"1000130","article-title":"Clinical Efficacy of a New Filmogen Polymeric Glycerol Solution for the Treatment of Rhinosinusitis","volume":"3","author":"Shrivastava","year":"2017","journal-title":"J. Clin. Respir. Dis. Care"},{"key":"ref_26","first-page":"1","article-title":"An Instant, Safe, Antihistamine, Anti-Inflammatory and Decongestant Polymeric Nasal Barrier to Prevent and To Treat Allergic Rhinitis in Children","volume":"7","author":"Shrivastava","year":"2021","journal-title":"J. Clin. Res. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Delmas, M., D\u2019Almeida, M., Dameron-Puech, S., Macian, N., Pickering, G., and Shrivastava, R. (2026). Tolerability, Efficacy, and Quality of Life Outcomes of Allerspray-G Nasal Spray in Adults with Allergic Rhinitis: Real-World Post-Marketing Clinical Trial. Allergies, 6.","DOI":"10.3390\/allergies6010008"},{"key":"ref_28","unstructured":"(2020). Clinical investigation of medical devices for human subjects\u2014Good clinical practice (Standard No. ISO 14155:2020)."},{"key":"ref_29","unstructured":"Shrivastava, R., Deshmukh, S., Rousse, M., Shrivastava, R., Deshmukh, S., and Rousse, M. (2013). Comparison of a Hypertonic Tannin-Rich Solution vs. 3% NaCl Solution as Treatment for Rhinosinusitis. AJPTR, 3."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.JAA.0000431519.28443.5e","article-title":"Acute Rhinosinusitis: New Guidelines for Diagnosis and Treatment","volume":"26","author":"Teeters","year":"2013","journal-title":"JAAPA"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pazdro-Zastawny, K., Krajewska, J., Kolator, M., Basiak-Rasa\u0142a, A., G\u00f3rna, S., and Zato\u0144ski, T. (2024). Dietary Habits, Physical Activity, and Self-Reported Rhinosinusitis in Children and Adolescents. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1290307"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Leffler, J., and Triggianese, P. (2023). Editorial: The Relationship between Puberty and Immune-Driven Disease. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1244240"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","article-title":"Evolution of the Immune System in Humans from Infancy to Old Age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc. R. Soc. B"},{"key":"ref_34","first-page":"1117","article-title":"Saline Nasal Irrigation for Upper Respiratory Conditions","volume":"80","author":"Rabago","year":"2009","journal-title":"Am. Fam. Physician"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00405-021-06916-0","article-title":"Observational Study Investigating Ectoin\u00ae Rhinitis Nasal Spray as Natural Treatment Option of Acute Rhinosinusitis Compared to Treatment with Xylometazoline","volume":"279","author":"Bilstein","year":"2022","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00405-016-4277-x","article-title":"Olfactory Dysfunction in Acute Rhinosinusitis: Intranasal Sodium Hyaluronate as Adjuvant Treatment","volume":"274","author":"Ciofalo","year":"2017","journal-title":"Eur. Arch. Otorhinolaryngol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:07:51Z","timestamp":1787663271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/9\/1631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medicina62091631"],"URL":"https:\/\/doi.org\/10.3390\/medicina62091631","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}